title: [Main clinical features and prognosis of AIDS patients with the predominance of thrombocytopenia].
abstract: OBJECTIVE
  To summarize the major clinical features, treatment, follow-up and outcomes of acquired immune deficiency syndrome (AIDS) patients with prominent thrombocytopenia.
  
  
  METHODS
  The manifestations, signs, anti-virus regimens, CD4 cell count, platelet count, prognosis and outcomes of 10 AIDS patients with prominent thrombocytopenia were collected and analyzed.
  
  
  RESULTS
  After the administration of highly active antiretroviral therapy, platelet count and CD4 significantly improved during a follow-up period up to 12 months. No opportunistic infections and HIV-related deaths occurred.
  
  
  CONCLUSIONS
  The HIV/AIDS patients with prominent thrombocytopenia should start highly active antiretroviral therapy so as to effectively improve the prognosis and outcome.
authors.affiliation: Center for Infectious Diseases, First Affiliated Hospital, Xinjiang Medical College, Urumqi 830054, China.
authors.forename: Maimaitiaili
authors.initials: M
authors.lastname: Wubuli
authors.forename: Ke-jun
authors.initials: KJ
authors.lastname: Pan
authors.forename: Xiao-feng
authors.initials: XF
authors.lastname: Sun
authors.forename: Yibaguli
authors.initials: Y
authors.lastname: Aibaidula
authors.forename: Yue-xin
authors.initials: YX
authors.lastname: Zhang
mesh_terms: D000163:Acquired Immunodeficiency Syndrome / Q000150:complications* / Q000175:diagnosis / Q000188:drug therapy*; D000293:Adolescent; D000328:Adult; D023241:Antiretroviral Therapy, Highly Active; D018791:CD4 Lymphocyte Count; D005260:Female; D015658:HIV Infections / Q000175:diagnosis / Q000188:drug therapy; D006801:Humans; D008297:Male; D008875:Middle Aged; D011379:Prognosis; D013921:Thrombocytopenia / Q000175:diagnosis / Q000209:etiology*; D055815:Young Adult